D. Western Therapeutics Institute, Inc. (TYO:4576)
Japan · Delayed Price · Currency is JPY 72.00
0.00 (0.00%)
Oct 6, 2026, 3:30 PM JST
TYO:4576 Market Cap
TYO:4576 has a market cap or net worth of 4.14 billion as of October 6, 2026. Its market cap has decreased by -17.65% in one year.
Market Cap
4.14B
Enterprise Value
3.15B
Revenue
247.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
72.00
ChartMarket Cap Chart
Since October 23, 2009, TYO:4576's market cap has decreased from 6.60B to 4.14B, a decrease of -37.23%. That is a compound annual growth rate of -2.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 4.14B | -20.44% |
| Dec 30, 2025 | 5.21B | -36.69% |
| Dec 30, 2024 | 8.23B | 81.59% |
| Dec 29, 2023 | 4.53B | -43.36% |
| Dec 30, 2022 | 8.00B | 26.13% |
| Dec 30, 2021 | 6.34B | -24.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TMS Co., Ltd. | 5.75B |
| Soiken Holdings | 5.62B |
| PRISM BioLab Co.,LTD | 5.40B |
| Noile-Immune Biotech | 5.08B |
| Chordia Therapeutics | 4.79B |
| Ribomic | 4.30B |
| Kohjin Bio | 4.21B |
| Transgenic Group | 4.06B |